Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size

Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease (CAD-AAA)

This study has been completed.
Sponsor:
Collaborators:
Kuopio University Hospital
Tampere University Hospital
Information provided by (Responsible Party):
Ville Vänni, North Karelia Central Hospital
ClinicalTrials.gov Identifier:
NCT01897623
First received: July 9, 2013
Last updated: December 15, 2014
Last verified: December 2014
History of Changes
  Purpose

The purpose of this study is to investigate the prevalence of abdominal aortic aneurysms (AAA) among male patients with coronary artery disease (CAD) verified in coronary angiography. Ethiology of AAA is known to be common with atherosclerotic arterial diseases (coronary artery disease, peripheral artery disease and carotid artery disease), so the hypothesis is that AAA should be more common among these CAD patients, thus making screening of these patients (for AAA) more cost-efficient.

Study will be carried out as a multi-center prospective screening study. Data will be collected in North Karelia Central Hospital, Kuopio University Hospital and Tampere University Hospital. Data consists of 200 consecutive coronary angiography patients in each hospital, resulting in 600 patients in total. All male patients with diagnosed CAD will be recruited for the study and screened for AAA with ultrasound. Nevertheless, patients with previously known AAA will be excluded from the study.


Condition Intervention
Abdominal Aortic Aneurysm
 Other: ultrasound of aorta

Study Type: Interventional
Study Design: Primary Purpose: Screening
Official Title: Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by North Karelia Central Hospital:

Primary Outcome Measures:
  • Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasound [ Time Frame: upon screening ] [ Designated as safety issue: No ]
Study Start Date: July 2013
Study Completion Date: October 2014
Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
ultrasound of aorta Other: ultrasound of aorta

  Eligibility
Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Male
Criteria

Inclusion Criteria:

  • Male patients with coronary artery disease

Exclusion Criteria:

  • Patient's denial to participate
  • Female Gender
  • Already diagnosed or treated abdominal aortic aneurysm
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01897623

Locations
Finland
North Carelia Central Hospital
Joensuu, Pohjois-Karjala, Finland, 80200
Sponsors and Collaborators
North Karelia Central Hospital
Kuopio University Hospital
Tampere University Hospital
  More Information

Responsible Party: Ville Vänni, General surgeon, North Karelia Central Hospital
ClinicalTrials.gov Identifier: NCT01897623     History of Changes
Other Study ID Numbers: AAA-CAD-02 
Study First Received: July 9, 2013
Last Updated: December 15, 2014
Health Authority: Finland: Ethics Committee
Finland: Valvira - National Supervisory Authority for Welfare and Health

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Aneurysm
Aortic Aneurysm
Aortic Aneurysm, Abdominal
 Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Aortic Diseases

ClinicalTrials.gov processed this record on September 27, 2016